Metgluco 250 mg from Japan tablets (type 2 diabetes)

What are Metgluco tablets 250 mg for type 2 diabetes (Glucophage, metformin)?

An active principle of Metgluco tablets is metformin, a hypoglycemic drug of biguanide class. Metgluco tablets are effective for the treatment of type 2 diabetes. The following effects can be expected:

• promoting sugar utilization in the muscles,
• suppressing sugar production in the liver,
• reducing sugar level in the blood,
• improving gut microbiota,
• providing an anorexiant effect, decreasing intake of calories.

Metgluco tablets are well tolerated and are not associated with weight gain. This medicine can be used alone as a first-line treatment due to the significantly lower risk of hypoglycemia and congestive heart disease. However, they can also be combined with other medications, including insulin. 

Active principles: metformin hydrochloride

Amount: 100 tablets

Maker: Sumitomo Pharma Co., Ltd., Tokyo, Japan

Indications: type 2 diabetes mellitus

How to take

Adults: start with 2 tablets (500 mg of active principle) a day, dividing this amount into 2 or 3 times, immediately before or after meals. Gradually increase the dosage up to the maintenance dose. Your doctor should prescribe the maintenance dose based on your response, usually 3-6 tablets a day, divided into 2 or 3 times. Your doctor may adjust the dose according to your symptoms. Maximum daily intake of 9 tablets should not be exceeded. 

Children 10 years and older: start with 2 tablets a day, dividing into 2 or 3 times, immediately before or after meals. Gradually increase the dose up to the maintenance dose. Your doctor should prescribe the maintenance dose based on your response, usually 2-6 tablets, divided into 2 or 3 times. Your doctor may adjust the dose according to your symptoms. Maximum daily dosage should not exceed 8 tablets.

Please note that this medicine contains 250 mg of active principle in 1 tablet.

Contraindications: do not use for the following patients:

• patients with a history of lactic acidosis,
• patients with renal or liver dysfunction, cardiovascular disorder, pulmonary dysfunction, hypoxemia, dehydration, gastrointestinal disorders such as diarrhea and vomiting, type 1 diabetes mellitus, infection, injury, pituitary malfunction or adrenal gland malfunction,
• patients receiving dialysis (including peritoneal dialysis),
• patients who drink excessive alcohol,
• patients in a state of ketosis, diabetic coma or precoma, malnutrition, starvation, debilitation or in a perioperative period,
• patients just before the test using iodinated contrast material, or within 2 days after it,
• pregnant, possibly pregnant or breastfeeding women. 

Important information

The patient must follow all instructions regarding diet and exercise therapy. 

Patient and their family should be informed about hypoglycemia precautions. If patient has any hypoglycemic symptoms, they should take foods containing sugar or glucose immediately. 

As this medicine can cause dizziness, patient should be cautious when driving a car, working at heights or operating dangerous machinery.

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.